Manufacturers

Drug control information for manufacturers, including but not limited to the manufacture of narcotic and psychotropic drugs in Australia.

Licences

Licences issued by the Office of Drug Control (ODC) for manufacturers of narcotic and psychotropic drugs.

Apply for a medicinal cannabis licence

View all licences

Permits

Permits issued by the Office of Drug Control (ODC) for manufacturers of narcotic and psychotropic drugs.

Apply to vary an existing medicinal cannabis permit – manufacture of cannabis drugs for medicinal or scientific purposes

View all permits

Information for manufacturers

Manufacture narcotic drugs in Australia

Manufacturing narcotic drugs in Australia
Cultivating and producing cannabis for medicinal or scientific purposes

Information for cultivators and producers of cannabis in Australia for medicinal or research purposes.
Reporting and compliance obligations for medicinal cannabis

How to submit quarterly reports, be ready for inspections, and what can happen if you don’t comply.

News

Cannatrek Technologies Pty Ltd fined $19,800 for alleged breaches of the Narcotic Drugs Act

23 July 2025

We have issued an infringement notice totalling $19,800 to Queensland-based company Cannatrek Technologies Pty Ltd (Cannatrek) for alleged breaches of its medicinal cannabis licence.
Office of Drug Control newsletter

16 June 2025

We have begun issuing a periodic newsletter designed to keep you informed about the latest developments, key topics, and important issues related to our work and engagement with the industry.
New substances controlled under the Customs (Prohibited Imports) Regulations 1956 and Customs (Prohibited Exports) Regulations 1958

5 March 2025

From 1 March 2025, new substances included under Schedule 4 of the Customs (Prohibited Imports) Regulations 1956 will require a licence and permit for import and/or export issued by us.

Resources

Guidance: Fees and charges

Guidance

Summary of fees and charges arising from the Australian Narcotic Drugs legislation and associated regulations.
Business plan: 2024-25

Publications

The Office of Drug Control Business Plan for 2024-25 is now available.
Guidance: Export of medicinal cannabis

Guidance

Guidance on export of medicinal cannabis and products.

Have your say

You can comment on Office of Drug Control reviews and reforms when we run public consultations on the Consultation hub. You'll find information about previous consultations on our consultation page.

Consultation hub - external site

Sub menu

Manufacturers

Licences

Apply for a medicinal cannabis licence

Permits

Apply to vary an existing medicinal cannabis permit – manufacture of cannabis drugs for medicinal or scientific purposes

Information for manufacturers

Manufacture narcotic drugs in Australia

Cultivating and producing cannabis for medicinal or scientific purposes

Reporting and compliance obligations for medicinal cannabis

News

Cannatrek Technologies Pty Ltd fined $19,800 for alleged breaches of the Narcotic Drugs Act

Office of Drug Control newsletter

New substances controlled under the Customs (Prohibited Imports) Regulations 1956 and Customs (Prohibited Exports) Regulations 1958

Resources

Guidance: Fees and charges

Business plan: 2024-25

Guidance: Export of medicinal cannabis

Have your say

Help us improve the Office of Drug Control site